Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
---|
06/05/2003 | US20030104974 Dual inhibitorsof PDE 7 and PDE 4 |
06/05/2003 | US20030104500 Enzymatic assays for screening anti-cancer agents |
06/05/2003 | US20030104406 Modified and stabilized GDF propeptides and uses thereof |
06/05/2003 | US20030104403 Nucleotide sequence coding transferase enzyme for use in treatment cancer |
06/05/2003 | US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins |
06/05/2003 | CA2468717A1 Aryl fused azapolycyclic compounds |
06/05/2003 | CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
06/05/2003 | CA2468240A1 Muscle transcription factors |
06/05/2003 | CA2468015A1 2-aminoquinoline compounds |
06/05/2003 | CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase |
06/05/2003 | CA2467825A1 Benzothiazole derivatives |
06/05/2003 | CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto |
06/05/2003 | CA2466845A1 Manipulation of cytokine levels using cd83 gene products |
06/04/2003 | EP1315800A2 Human proteases |
06/04/2003 | EP1315758A2 Methods and reagents for protease inhibition |
06/04/2003 | EP1315735A1 Phosphate derivatives as immunoregulatory agents |
06/04/2003 | EP1315502A1 Method for treating erectile dysfunction and increasing libido in men |
06/04/2003 | EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
06/04/2003 | EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
06/04/2003 | EP0789578B1 Multicatalytic protease inhibitors |
06/04/2003 | EP0775118B1 Benzimidazole derivatives having dopaminergic activity |
06/04/2003 | EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
06/04/2003 | EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
06/04/2003 | CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
06/04/2003 | CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors |
06/04/2003 | CN1110499C Spiro-quinuclidine derivatives, their preparation and use |
06/03/2003 | US6573264 Heteroaryl alkyl piperazine derivatives |
06/03/2003 | US6573243 Pompilid wasp-derived neuropeptides |
06/03/2003 | US6572858 Uses for anti-malarial therapeutic agents |
05/30/2003 | WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
05/30/2003 | WO2003044021A2 Substituted indolizine-like compounds and methods of use |
05/30/2003 | WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
05/30/2003 | WO2003043651A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
05/30/2003 | WO2003043634A1 Benzothiazole derivatives as adenosine receptor ligands |
05/30/2003 | WO2003043619A1 New use for the treatment of gastroesophageal reflux disease |
05/30/2003 | WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof |
05/30/2003 | WO2003008448A3 Novel human proton-gated channels |
05/30/2003 | WO2003005998A3 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent of modulating cholinergic function |
05/30/2003 | WO2002096363A3 Method for treating fibrotic diseases or other indications |
05/30/2003 | WO2002088100A3 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
05/30/2003 | CA2467557A1 Agent which mobilizes multipotential stem cells from tissues to peripheral blood |
05/30/2003 | CA2467551A1 Benzothiazole derivatives as adenosine receptor ligands |
05/30/2003 | CA2466916A1 New use for the treatment of gastroesophageal reflux disease |
05/30/2003 | CA2466072A1 Substituted indolizine-like compounds and methods of use |
05/30/2003 | CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
05/29/2003 | US20030100609 Orally ingesting a quantity of calcium formate sufficient to improve calcium balance or retention |
05/29/2003 | US20030100607 Thiolalkyl benzoic acid derivatives |
05/29/2003 | US20030100603 Administering to the patient subject to a C-reactive protein associated inflammatory condition, an effective amount of a non-alpha-tocopherol enriched tocopherol |
05/29/2003 | US20030100594 Carbonic anhydrase inhibitor |
05/29/2003 | US20030100577 Neurotrophic agents in treatment of solid tumors and vascular disease |
05/29/2003 | US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission |
05/29/2003 | US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
05/29/2003 | US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors |
05/29/2003 | US20030100542 5-hydroxysapogenin derivatives with anti-dementia activity |
05/29/2003 | US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers |
05/28/2003 | EP1314980A2 A system for cell-based screening |
05/28/2003 | EP1314723A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
05/28/2003 | EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
05/28/2003 | EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
05/28/2003 | EP1313854A2 Transporters and ion channels |
05/28/2003 | EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof |
05/28/2003 | EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors |
05/28/2003 | EP1313707A1 Quinoline derivatives as anti-inflammation agents |
05/28/2003 | EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists |
05/28/2003 | EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema |
05/28/2003 | EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
05/28/2003 | EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
05/28/2003 | EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
05/28/2003 | EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
05/28/2003 | EP0786995B1 Use of 5-(tetradecyloxy)-2-furan carboxylic acid for treating alzheimer's disease or psychosis |
05/28/2003 | CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha |
05/28/2003 | CN1420878A Compound with growth hormone releasing properties |
05/28/2003 | CN1420872A Caspase inhibitors and use thereof |
05/28/2003 | CN1420870A Modulators of dopamine neurotransmission |
05/28/2003 | CN1420770A Method of delivery of cetyl myristoleate |
05/27/2003 | US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity |
05/27/2003 | US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease |
05/27/2003 | US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives |
05/27/2003 | US6569468 Treatment of urogenital disorders, menstrual cramps |
05/27/2003 | US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides |
05/27/2003 | CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases |
05/27/2003 | CA2412466A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
05/22/2003 | WO2003042405A2 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
05/22/2003 | WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
05/22/2003 | WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
05/22/2003 | WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
05/22/2003 | WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
05/22/2003 | WO2003042113A1 Production of cell suspensions |
05/22/2003 | WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
05/22/2003 | WO2003041713A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
05/22/2003 | WO2003041697A1 Method for treating autoimmune diseases |
05/22/2003 | WO2003041684A2 Injectable depot compositions and uses thereof |
05/22/2003 | WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors |
05/22/2003 | WO2002096362A3 Method for treating fibrotic diseases or other indications vi |
05/22/2003 | WO2002045749A8 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4 |
05/22/2003 | WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
05/22/2003 | US20030096873 Administering therapeutically effective amount of (+)-bupropion or a pharmaceutically acceptable salt thereof, substantially free of its (-)-stereoisomer for therapy of pain |
05/22/2003 | US20030096844 Cannabinoid receptor ligands |
05/22/2003 | US20030096838 Novel triazolo-pyridines anti-inflammatory compounds |